APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transient Receptor Potential Cation Channel Subfamily V Member 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchTransient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transient Receptor Potential Cation Channel Subfamily V Member 1 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Transient Receptor Potential Cation Channel Subfamily V Member 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company

Amgen Inc

Vitality Biopharma Inc

Toray Industries Inc

Sylentis SAU

Pila Pharma AB

Neurim Pharmaceuticals Ltd

Medifron DBT Co Ltd

Kyowa Hakko Kirin Co Ltd

Grunenthal GmbH

Flex Pharma Inc

DoNatur GmbH

Daewoong Pharmaceutical Co Ltd

Centrexion Therapeutics Corp

BCN Peptides SA

Amorepacific Corp

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107

CMX-020

CA-016

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain

Muscle Spasm

Immunology

Pruritus

Ophthalmology

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Transient Receptor Potential Cation Channel Subfamily V Member 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transient Receptor Potential Cation Channel Subfamily V Member 1 industry.

Chapter 3: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transient Receptor Potential Cation Channel Subfamily V Member 1revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DD-04107 Table 3. Key Players of CMX-020 Table 4. Key Players of CA-016 Table 3. Key Players of Others Table 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Abdominal Pain Table 6. Key Players of Muscle Spasm Table 7. Key Players of Immunology Table 8. Key Players of Pruritus Table 9. Key Players of Ophthalmology Table 10. Key Players of Others Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2021-2026) Table 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2027-2032) Table 16. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends Table 17. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers Table 18. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges Table 19. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints Table 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company (2021-2026) Table 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Company Head Office and Area Served Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company, Product Type & Application Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2026) Table 32. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2027-2032) Table 33. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2026) Table 37. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2027-2032) Table 38. Amgen Inc Company Information Table 39. Amgen Inc Business Overview Table 40. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 42. Amgen Inc Recent Development Table 43. Vitality Biopharma Inc Company Information Table 44. Vitality Biopharma Inc Business Overview Table 45. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 47. Vitality Biopharma Inc Recent Development Table 48. Toray Industries Inc Company Information Table 49. Toray Industries Inc Business Overview Table 50. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 52. Toray Industries Inc Recent Development Table 53. Sylentis SAU Company Information Table 54. Sylentis SAU Business Overview Table 55. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 57. Sylentis SAU Recent Development Table 58. Pila Pharma AB Company Information Table 59. Pila Pharma AB Business Overview Table 60. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 62. Pila Pharma AB Recent Development Table 63. Neurim Pharmaceuticals Ltd Company Information Table 64. Neurim Pharmaceuticals Ltd Business Overview Table 65. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 67. Neurim Pharmaceuticals Ltd Recent Development Table 68. Medifron DBT Co Ltd Company Information Table 69. Medifron DBT Co Ltd Business Overview Table 70. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 72. Medifron DBT Co Ltd Recent Development Table 73. Kyowa Hakko Kirin Co Ltd Company Information Table 74. Kyowa Hakko Kirin Co Ltd Business Overview Table 75. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 77. Kyowa Hakko Kirin Co Ltd Recent Development Table 78. Grunenthal GmbH Company Information Table 79. Grunenthal GmbH Business Overview Table 80. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 82. Grunenthal GmbH Recent Development Table 83. Flex Pharma Inc Company Information Table 84. Flex Pharma Inc Business Overview Table 85. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 87. Flex Pharma Inc Recent Development Table 88. DoNatur GmbH Company Information Table 89. DoNatur GmbH Business Overview Table 90. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 92. DoNatur GmbH Recent Development Table 93. Daewoong Pharmaceutical Co Ltd Company Information Table 94. Daewoong Pharmaceutical Co Ltd Business Overview Table 95. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 97. Daewoong Pharmaceutical Co Ltd Recent Development Table 98. Centrexion Therapeutics Corp Company Information Table 99. Centrexion Therapeutics Corp Business Overview Table 100. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 102. Centrexion Therapeutics Corp Recent Development Table 103. BCN Peptides SA Company Information Table 104. BCN Peptides SA Business Overview Table 105. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 107. BCN Peptides SA Recent Development Table 108. Amorepacific Corp Company Information Table 109. Amorepacific Corp Business Overview Table 110. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 112. Amorepacific Corp Recent Development Table 113. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 114. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 115. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 116. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 117. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) Table 119. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) Table 120. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 121. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 122. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 123. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 124. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) Table 126. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) Table 127. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 128. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 129. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 130. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 132. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 133. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 134. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) Table 137. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) Table 138. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) Table 144. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Image Figure 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2025 VS 2032 Figure 4. DD-04107 Image Figure 5. CMX-020 Image Figure 6. CA-016 Image Figure 7. Others Image Figure 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2025 VS 2032 Figure 10. Abdominal Pain Image Figure 11. Muscle Spasm Image Figure 12. Immunology Image Figure 13. Pruritus Image Figure 14. Ophthalmology Image Figure 15. Others Image Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2032) Figure 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2032) Figure 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 28. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032) Figure 29. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032) Figure 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 31. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 32. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032) Figure 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032) Figure 37. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 38. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 39. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 41. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 42. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 44. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 45. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032) Figure 46. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032) Figure 47. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 48. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032) Figure 49. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032) Figure 50. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 51. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 55. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 56. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 61. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 66. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 68. Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • DD-04107
  • CMX-020
  • CA-016
  • Others
Applications
  • Abdominal Pain
  • Muscle Spasm
  • Immunology
  • Pruritus
  • Ophthalmology
  • Others
Companies covered
  • Amgen Inc
  • Vitality Biopharma Inc
  • Toray Industries Inc
  • Sylentis SAU
  • Pila Pharma AB
  • Neurim Pharmaceuticals Ltd
  • Medifron DBT Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Grunenthal GmbH
  • Flex Pharma Inc
  • DoNatur GmbH
  • Daewoong Pharmaceutical Co Ltd
  • Centrexion Therapeutics Corp
  • BCN Peptides SA
  • Amorepacific Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DD-04107
  5. 1.2.3 CMX-020
  6. 1.2.4 CA-016
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Abdominal Pain
  11. 1.3.3 Muscle Spasm
  12. 1.3.4 Immunology
  13. 1.3.5 Pruritus
  14. 1.3.6 Ophthalmology
  15. 1.3.7 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
  18. 1.5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026)
  20. 1.5.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
  1. 2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
  2. 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
  3. 2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
  4. 2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2026)
  2. 3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Company Head office and Area Served
  4. 3.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company, Product Type & Application
  5. 3.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Transient Receptor Potential Cation Channel Subfamily V Member 1 Tier 1, Tier 2, and Tier 3
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
  1. 4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2032)
  3. 4.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type (2021-2032)
5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application
  1. 5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2032)
  3. 5.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Amgen Inc
  2. 6.1.1 Amgen Inc Company Information
  3. 6.1.2 Amgen Inc Business Overview
  4. 6.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  6. 6.1.5 Amgen Inc Recent Developments
  7. 6.2 Vitality Biopharma Inc
  8. 6.2.1 Vitality Biopharma Inc Company Information
  9. 6.2.2 Vitality Biopharma Inc Business Overview
  10. 6.2.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  12. 6.2.5 Vitality Biopharma Inc Recent Developments
  13. 6.3 Toray Industries Inc
  14. 6.3.1 Toray Industries Inc Company Information
  15. 6.3.2 Toray Industries Inc Business Overview
  16. 6.3.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  18. 6.3.5 Toray Industries Inc Recent Developments
  19. 6.4 Sylentis SAU
  20. 6.4.1 Sylentis SAU Company Information
  21. 6.4.2 Sylentis SAU Business Overview
  22. 6.4.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  24. 6.4.5 Sylentis SAU Recent Developments
  25. 6.5 Pila Pharma AB
  26. 6.5.1 Pila Pharma AB Company Information
  27. 6.5.2 Pila Pharma AB Business Overview
  28. 6.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  30. 6.5.5 Pila Pharma AB Recent Developments
  31. 6.6 Neurim Pharmaceuticals Ltd
  32. 6.6.1 Neurim Pharmaceuticals Ltd Company Information
  33. 6.6.2 Neurim Pharmaceuticals Ltd Business Overview
  34. 6.6.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  36. 6.6.5 Neurim Pharmaceuticals Ltd Recent Developments
  37. 6.7 Medifron DBT Co Ltd
  38. 6.7.1 Medifron DBT Co Ltd Company Information
  39. 6.7.2 Medifron DBT Co Ltd Business Overview
  40. 6.7.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  42. 6.7.5 Medifron DBT Co Ltd Recent Developments
  43. 6.8 Kyowa Hakko Kirin Co Ltd
  44. 6.8.1 Kyowa Hakko Kirin Co Ltd Company Information
  45. 6.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
  46. 6.8.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  48. 6.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  49. 6.9 Grunenthal GmbH
  50. 6.9.1 Grunenthal GmbH Company Information
  51. 6.9.2 Grunenthal GmbH Business Overview
  52. 6.9.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  54. 6.9.5 Grunenthal GmbH Recent Developments
  55. 6.10 Flex Pharma Inc
  56. 6.10.1 Flex Pharma Inc Company Information
  57. 6.10.2 Flex Pharma Inc Business Overview
  58. 6.10.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  60. 6.10.5 Flex Pharma Inc Recent Developments
  61. 6.11 DoNatur GmbH
  62. 6.11.1 DoNatur GmbH Company Information
  63. 6.11.2 DoNatur GmbH Business Overview
  64. 6.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  66. 6.11.5 DoNatur GmbH Recent Developments
  67. 6.12 Daewoong Pharmaceutical Co Ltd
  68. 6.12.1 Daewoong Pharmaceutical Co Ltd Company Information
  69. 6.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
  70. 6.12.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  72. 6.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  73. 6.13 Centrexion Therapeutics Corp
  74. 6.13.1 Centrexion Therapeutics Corp Company Information
  75. 6.13.2 Centrexion Therapeutics Corp Business Overview
  76. 6.13.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  78. 6.13.5 Centrexion Therapeutics Corp Recent Developments
  79. 6.14 BCN Peptides SA
  80. 6.14.1 BCN Peptides SA Company Information
  81. 6.14.2 BCN Peptides SA Business Overview
  82. 6.14.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  84. 6.14.5 BCN Peptides SA Recent Developments
  85. 6.15 Amorepacific Corp
  86. 6.15.1 Amorepacific Corp Company Information
  87. 6.15.2 Amorepacific Corp Business Overview
  88. 6.15.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  90. 6.15.5 Amorepacific Corp Recent Developments
7 North America
  1. 7.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 7.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  3. 7.2.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026)
  4. 7.2.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032)
  5. 7.2.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032)
  6. 7.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  7. 7.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026)
  8. 7.3.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032)
  9. 7.3.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032)
  10. 7.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
  11. 7.4.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  13. 7.4.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  14. 7.4.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 8.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  3. 8.2.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032)
  6. 8.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  7. 8.3.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032)
  10. 8.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
  11. 8.4.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 9.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  3. 9.2.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026)
  4. 9.2.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032)
  5. 9.2.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032)
  6. 9.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  7. 9.3.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026)
  8. 9.3.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032)
  9. 9.3.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 10.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  3. 10.2.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032)
  6. 10.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  7. 10.3.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032)
  10. 10.4 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
  11. 10.4.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst